日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Baseline glucose-to-lymphocyte ratio predicts nivolumab outcomes in advanced non-small cell lung cancer: a multicenter retrospective study

基线葡萄糖/淋巴细胞比值可预测晚期非小细胞肺癌患者接受纳武利尤单抗治疗的疗效:一项多中心回顾性研究

Ersoy, Mustafa; Kefeli, Umut; Cabuk, Devrim; Bayram, Ertugrul; Bayir, Duygu; Bozkurt, Oktay; Ürün, Muslih; Coşar, Ramazan; Sakalar, Teoman; Mutlu, Emel; Cengiz, Muhammet; Sahin, Elif; Sancı, Pervin; Yıldız, Canan; Kolemen, Erdem; Cengiz, Ayse; Agdas, Gozde; Kocaaslan, Erkam; Turkoglu, Ezgi; Yıldırım, Sedat; Mermeit, Berrak; Karakayalı, Anil; Arvas, Hayati; Mutlu, Mehmet; Biter, Sedat; Yeşil Çinkir, Havva; Yücel, Mehmet H

Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study

曲妥珠单抗德鲁替康治疗HER2阳性转移性乳腺癌患者的真实世界疗效:土耳其肿瘤协作组多中心研究

Sahin, Taha Koray; Kemik, Fatih; Muglu, Harun; Acikgöz Yildiz, Bedriye; Biter, Sedat; Tunbekici, Salih; Oruc, Ahmet; Guren, Ali Kaan; Kaban, Kerim; Guzel, Halil Goksel; Erol, Cihan; Aykan, Musa Baris; Koylu, Bahadir; Ekinci, Omer Burak; Deliktas Onur, Ilknur; Kalem, Ali; Altunok, Oguz; Seyyar, Mustafa; Guney, Bunyamin; Akdogan, Orhun; Ismayilov, Rashad; Ardic, Fadime Sinem; Yazici, Melike; Majidova, Nargiz; Turker, Sema; Esin, Ece; Cabuk, Devrim; Yasar, Hatime Arzu; Oguz, Arzu; Yazici, Ozan; Gursu, Riza Umar; Yılmaz, Mesut; Yesil Cinkir, Havva; Ates, Ozturk; Celik, Emir; Karadurmus, Nuri; Demirci, Umut; Ozturk, Banu; Mandel, Nil Molinas; Bayoglu, Ibrahim Vedat; Araz, Murat; Goker, Erdem; Bayram, Ertugrul; Erdem, Dilek; Selcukbiricik, Fatih; Basaran, Gul; Sezer, Ahmet; Dogu, Gamze Gokoz; Kemal, Yasemin; Bilici, Ahmet; Gunduz, Seyda; Guven, Deniz Can; Aksoy, Sercan

The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer

晚期肺癌免疫治疗患者肺部免疫预后指数早期变化的预后意义

Cengiz, Muhammet; Bozkurt, Oktay; Nuransoy Cengiz, Ayşe; Inanc, Mevlude; Ozkan, Metin; Mutlu Ozkan, Emel; Guven, Deniz Can; Erman, Mustafa; Karahan, Latif; Sahin, Elif; Karakayali, Anıl; Can Sanci, Pervin; Kefeli, Umut; Cabuk, Devrim; Kolemen, Erdem; Kidi, Mehmet Mutlu; Biter, Sedat; Koseci, Tolga; Urun, Muslih; Mermit Ercek, Berrak; Bayir, Duygu; Agdas, Gözde; Sakalar, Teoman; Majidova, Nargiz; Yildiz, Sedat; Demir, Hacer; Akosman, Cengiz; Ersoy, Mustafa; Kilickap, Saadettin; Kocaaslan, Erkam; Turkoğlu, Ezgi; Yildirim, Sedat; Arvas, Hayati; Yesil Cinkir, Havva; Apaydin Rollas, Aslihan Ezgi

Prognostic Significance of C-PLAN Index in Patients Treated with Immunotherapy for Non-Small-Cell Lung Cancer

C-PLAN 指数在接受免疫治疗的非小细胞肺癌患者中的预后意义

Nuransoy Cengiz, Ayse; Bozkurt, Oktay; Cengiz, Muhammet; Ozkan, Metin; Inanc, Mevlude; Kefeli, Umut; Cabuk, Devrim; Erman, Mustafa; Kilickap, Saadettin; Koseci, Tolga; Bayir, Duygu; Guven, Deniz Can; Urun, Muslih; Cosar, Ramazan; Sakalar, Teoman; Majidova, Nargiz; Mutlu Ozkan, Emel; Akosman, Cengiz; Ersoy, Mustafa; Sahin, Elif; Can Sanci, Pervin; Yildiz, Canan; Kolemen, Erdem; Agdas, Gözde; Kocaaslan, Erkam; Turkoğlu, Ezgi; Yildirim, Sedat; Mermit Ercek, Berrak; Karakayali, Anıl; Arvas, Hayati; Kidi, Mehmet Mutlu; Biter, Sedat; Yesil Cinkir, Havva; Karahan, Latif; Apaydin Rollas, Aslihan Ezgi

Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis

卵巢癌一线PARP抑制剂治疗的疗效:一项多中心回顾性分析

Koksal, Baris; Yildirim, Hasan Cagri; Guven, Deniz Can; Kose, Fatih; Koymen, Gorkem; Ozdemir, Ozlem; Ozberk, Ugur; Algin, Efnan; Guliyev, Murad; Demirci, Nebi Serkan; Alan, Ozkan; Baklaci, Ahmet; Demir, Bilgin; Topkaya, Ozlem; Uskent, Necdet; Yucel, Kadriye Bir; Akdogan, Orhun; Koylu, Bahadir; Selcukbiricik, Fatih; Bilgetekin, Irem; Helvaci, Kaan; Unal, Ahmet; Semiz, Huseyin Salih; Sakalar, Teoman; Sever, Nadiye; Cicek, Ceren Mordag; Dogu, Gamze Gokoz; Biter, Sedat; Bayram, Ertugrul; Yildiz, Canan; Demir, Hacer; Bayrakci, Ismail; Erdogan, Bulent; Kalender, Mehmet Emin; Guzel, Halil Goksel; Ozturk, Banu; Karabuga, Berkan; Ates, Ozturk; Cetin, Emine Bihter; Sahbazlar, Mustafa; Inal, Ali; Sunar, Veli; Basal, Fatma Bugdayci; Asik, Esra; Yildirim, Atila; Oksuz, Nejat Emre; Urun, Yuksel; Nayir, Erdinc; Turker, Sema; On, Sercan; Aytac, Ali; Menekse, Serkan; Temi, Yasemin Bakkal; Uygun, Kazim; Sahin, Elif; Keskinkilic, Merve; Arik, Zafer

Can ChatGPT compete with emergency medicine specialists? A two-stage assessment of ECG interpretation supported by clinical information

ChatGPT能否与急诊医学专家竞争?基于临床信息的两阶段心电图判读评估

Umit, Tuba Betul; Arslan, Muge; Inan, Gulin; Fettahoglu, Sureyya Tuba; Yildız, Asli; Sarbay, Ibrahim; Taskan, Hatice; Biter, Halil Ibrahim; Sogut, Ozgur

Health-related quality of life and psychosocial outcomes in long-term survivors treated with immune checkpoint inhibitors: a nationwide multicenter study

接受免疫检查点抑制剂治疗的长期生存者的健康相关生活质量和心理社会结局:一项全国多中心研究

Sahin, Taha Koray; Atalah, Fatih; Koylu, Bahadir; Oruc, Ahmet; Acarbay, Aydin; Karakok, Akgun; Dogan, Sevgi; Kikili, Cevat Ilteris; Turhan, Görkem; Emin, Gamze; Celik, Selahattin; Deliktas Onur, Ilknur; Tuzcu, Tuba Ugur; Biter, Sedat; Efil, Safa Can; Ardic, Fadime Sinem; Gokmen, Azer; Guzel, Halil Goksel; Turan, Kadri; Disli, Ahmet Kürsad; Tunbekici, Salih; Goker, Erdem; Inanc, Mevlude; Ozdemir, Ozlem; Ozturk, Banu; Urun, Muslih; Yasar, Hatime Arzu; Sendur, Mehmet Ali Nahit; Kara, Ismail Oguz; Sutcuoglu, Osman; Ates, Ozturk; Eren, Tulay; Yildirim, Atila; Kilickap, Saadettin; Dizdar, Omer; Turker, Fatma Alev; Erman, Mustafa; Artac, Mehmet; Selcukbiricik, Fatih; Aksoy, Sercan; Guven, Deniz Can

Durvalumab-Based First-Line Chemoimmunotherapy in Advanced Biliary Tract Cancer: Real-World Outcomes and Prognostic Factors-A Turkish Oncology Group Study

以度伐利尤单抗为基础的一线化疗免疫疗法治疗晚期胆道癌:真实世界结果和预后因素——一项土耳其肿瘤协作组研究

Efil, Safa Can; Kus, Fatih; Koylu, Bahadir; Durukan, Bekir Mert; Bayram, Selami; Guzel, Halil Goksel; Ozturk, Banu; Muglu, Harun; Bilici, Ahmet; Kose, Fatih; Alan, Ozkan; Karapelit Agitoglu, Eda; Guner, Gurkan; Besen, Ali Ayberk; Helvaci, Kaan; Araz, Murat; Kacan, Turgut; Arslan, Cagatay; Unal, Ahmet; Eniseler, Emine Bihter; Biter, Sedat; Ekinci, Ferhat; Aslan, Ferit; Unek, Ilkay Tugba; Tas, Semra; Acar, Omer; Ates, Ozturk; Sakalar, Teoman; Akbas, Sinem; Karakas, Hilal; Akinci, Muhammed Bulent; Yalcin, Bulent; Yalcin, Suayip; Sendur, Mehmet Ali Nahit

Prognostic and predictive value of systemic inflammatory markers in patients with metastatic gastric and GEJ adenocarcinoma with PD-L1 CPS score ≥ 5: Turkish Oncology Group (TOG) study

系统性炎症标志物在PD-L1 CPS评分≥5的转移性胃癌和胃食管交界处腺癌患者中的预后和预测价值:土耳其肿瘤协作组(TOG)研究

Mildanoglu, Maral Martin; Kutlu, Yasin; Bas, Onur; Koylu, Bahadır; Dae, Shute Ailia; Sakin, Abdullah; Erdem, Dilek; Sendur, Mehmet Ali Nahit; Tasci, Elif Senocak; Dane, Faysal; Kaya, Ali Osman; Aykan, Musa Baris; Ergun, Yakup; Biter, Sedat; Dizdar, Omer; Disel, Umut; Selcukbiricik, Fatih; Kose, Fatih; Olmez, Omer Fatih; Demir, Gokhan; Yalcin, Suayib; Bilici, Ahmet

Prognostic impact of hand-foot skin reaction in regorafenib-treated adult-type diffuse gliomas: A multicenter Turkish Oncology Group study

瑞戈非尼治疗成人型弥漫性胶质瘤中手足皮肤反应的预后影响:一项土耳其肿瘤协作组多中心研究

Efil, Safa Can; Bilgin, Burak; Bilgetekin, Irem; Helvaci, Kaan; Sakalar, Teoman; Nayir, Erdinc; Erdem Palaz, Fatma Esra; Guren, Ali Kaan; Biter, Sedat; Sahin, Taha Koray; Bayram, Ertugrul; Kertmen, Neyran; Arslan, Ahmet Melih; Asık, Esra; Akdogan, Orhun; Alan, Ozkan; Fidan, Evren; Yazici, Ozan; Sahin, Elif; Kut, Engin; Mordag Cicek, Ceren; Turker, Sema; Kolkiran, Nagihan; Gokoz Dogu, Gamze; Sahbazlar, Mustafa; Batu, Aziz; Kilictas, Bilgesah; Yilmaz, Mesut; Oksuz, Nejat Emre; Artac, Mehmet; Akbas, Sinem; Algin, Efnan; Urun, Yuksel; Sendur, Mehmet Ali Nahit; Yalcin, Bulent